Acute Lymphoblastic Leukemia: Challenges in MRD Testing
2 Просмотры
• 08/04/23
0
0
встраивать
administrator
Подписчики
Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.
Показать больше
Комментарии Facebook
SORT BY-
Лучшие комментарии
-
Последние комментарии